Artificial Intelligence Is Poised to Transform Point-of-Care Testing As more tests move out of the core laboratory and are performed by nonlaboratory professionals, artificial intelligence and machine learning are being used to make POCT cheaper, faster, and easier to check for quality control. Learn More
Search A for HbA1C A new initiative among laboratory professionals aims to tackle confusion over test names and ensure clinicians order the right test, at the right time, for the right patient. Learn More
Using Human Chorionic Gonadotropin as a Tumor Marker Kevin F. Foley, PhD, MT, DABCC provides an overview of what labs need to know about using human chorionic gonadotropin as a tumor marker. Learn More
Result, Dilute, Comment, or Cancel: How to Handle Icteric Samples One laboratory describes how programming instruments has helped analyze results of icteric samples that exceed the acceptable I-index cutoff. Through an automated process, the instruments have the ability to determine one of three courses of action – dilute the sample, provide results with comments, or cancel the results altogether. Learn More
COVID-19 Relief Bill Devotes $48 Billion to Testing The $1.9 trillion American Rescue Plan outlines key areas that will be covered with the $47.8 billion set aside for the Department of Health and Human Services to spend on SARS-CoV-2 testing. Learn More
Veracyte Acquires Decipher for $600 Million In a $600 million agreement, Veracyte will acquire Decipher Biosciences to accelerate commercialization of tests in the genomic cancer diagnostics market. Learn More
How Precision Medicine Combats Underused Genomic Testing The rapid rate of practice-changing developments in cancer care makes it challenging for medical oncologists to stay up to date. Experts in the field dive into the issue and address potential solutions to ensure the best patient care. Learn More
The Building Blocks of a Pharmacogenomic Program Jennifer Eichmeyer, MS, CGC, and Christine Munro, MS, MPH, CGC explore the need for developing a pharmacogenomic program and where to start in the rapidly growing field. Learn More
FDA Clears AI-Based Software That Predicts Hemodynamic Instability in ICU Patients CLEW Medical, a company that specializes in artificial intelligence-powered predictive analytics, has received Food and Drug Administration 510(k) clearance for CLEWICU, the company’s AI-based intensive care unit software that predicts hemodynamic instability in adult patients. Learn More
Stepping Up During a Global Pandemic CLN’s Special Supplement highlights five COVID-19- related initiatives in clinical laboratories that were recognized with “distinction” or with “achievement” in the 2020 UNIVANTS of Healthcare Excellence Program. Learn More
Options for Thyroid Testing During Pregnancy Recommended Indirect free thyroxine immunoassay results may provide a practical and viable alternative to total T4 or free thyroxine index in pregnancy, as long as they’re interpreted in the context of trimester-specific reference intervals, according to researchers. Learn More